Skip to main content
. Author manuscript; available in PMC: 2020 Oct 13.
Published in final edited form as: Obstet Gynecol. 2016 Oct;128(4):761–770. doi: 10.1097/AOG.0000000000001647

Table 3.

Multivariable Analysis for Women Aged Younger Than 50 Years With Stage I Grade 1 Endometrioid Endometrial Cancer (n=9,110)

Overall Survival
Death From Cardiovascular Disease
Multivariable
Multivariable
n 10-y 20-y HR (95% CI) P 10-y 20-y HR (95% CI) P

Age (y)
 40–49 6,923 93.8 82.3 1 1.0 3.4 1
 30–39 1,980 94.1 84.0 0.80 (0.66–0.98) .034 1.1 3.7 0.82 (0.52–1.32) .42
 Younger than 30 207 98.3 86.1 0.60 (0.33–1.10) .10 0.6 3.9 0.60 (0.14–2.50) .48
Ethnicity
 White 5,824 94.2 83.7 1 1.0 3.4 1
 Black 478 88.8 73.7 1.81 (1.32–2.48) <.001 3.7 8.5 3.75 (2.05–6.83) <.001
 Hispanic 1,427 94.4 82.4 1.07 (0.82–1.40) .62 0.6 1.7 0.66 (0.30–1.46) .31
 Asian 950 94.5 83.4 0.83 (0.61–1.13) .25 0.7 3.5 0.65 (0.29–1.45) .30
 Others 387 94.5 68.6 1.80 (1.28–2.53) .001 0.8 4.2 1.76 (0.78–3.97) .17
 Unknown 44 100 100 NA .88 0 0 NA .97
Marital status
 Single 2,474 91.4 78.8 1 1.4 4.8 1
 Others 6,277 94.8 84.1 0.68 (0.57–0.81) <.001 0.9 3.2 0.79 (0.52–1.20) .27
 Unknown 359 94.6 80.3 0.91 (0.59–1.39) .65 1.4 1.4 0.71 (0.22–2.35) .58
Registry area
 West 4,987 93.9 82.6 1 0.8 3.5 1
 Central 2,010 93.6 82.5 1.05 (0.86–1.28) .66 1.8 3.8 0.97 (0.62–1.52) .89
 East 2,113 94.3 83.2 0.89 (0.71–1.10) .27 0.9 3.4 0.82 (0.50–1.36) .44
Year of diagnosis
 1983–1989 641 95.6 83.4 1 1.0 3.7 1
 1990–1999 1,814 93.8 83.3 1.05 (0.83–1.33) .66 1.4 4.1 1.04 (0.63–1.72) .88
 2000–2009 5,070 93.4 92.4 1.09 (0.83–1.43) .55 1.0 NR 0.56 (0.29–1.09) .09
 2010–2012 1,585 NR NR 0.40 (0.16–1.02) .06 NR NR 0.43 (0.05–3.52) .43
Stage
 IA 7,894 94.1 83.1 1 1.1 3.5 1
 IB 258 88.5 78.2 1.40 (0.86–2.26) .18 1.5 9.3 2.12 (0.74–6.07) .16
 I NOS 958 93.3 81.3 1.16 (0.94–1.44) .17 1.0 3.2 1.11 (0.69–1.78) .68
Tumor size (cm)
 2.0 or less 2,040 94.7 86.5 0.72 (0.44–1.18) .20 1.2 4.3 3.28 (0.43–23.9) .25
 2.1–4.0 1,153 94.7 79.7 0.78 (0.47–1.32) .35 1.3 3.5 3.03 (0.39–23.4) .29
 4.1–6.0 576 94.4 71.8 0.87 (0.48–1.57) .64 0.2 5.1 2.03 (0.21–19.6) .54
 Greater than 6.0 350 90.2 70.4 1 0.3 0.3 1
 Unknown 4,991 93.6 82.2 0.86 (0.54–1.37) .51 1.0 3.2 2.58 (0.35–18.6) .35
Surgery type
 Total, pan, simple hysterectomy 8,147 94.0 82.7 1 1.0 3.5 1
 Supracervical, subtotal hysterectomy 811 93.2 82.5 0.98 (0.77–1.24) .87 0.6 3.0 0.54 (0.28–1.04) .07
 Others 152 92.2 NR 1.37 (0.64–2.90) .42 3.3 NR 3.95 (0.94–16.6) .06
Adjuvant radiation
 No 8,646 94.0 82.8 1 1.1 3.6 1
 Yes 399 92.3 80.6 1.22 (0.90–1.67) .21 0.7 3.4 1.09 (0.53–2.24) .81
 Unknown 65 97.9 95.3 0.59 (0.18–1.89) .37 0 0 NA .95
Ovarian conservation
 No 8,076 93.7 82.0 1 1.1 3.7 1
 Yes 1,034 95.6 88.8 0.73 (0.54–0.98) .036 0.2 2.3 0.40 (0.17–0.91) .029

HR, hazard ratio; CI, confidence interval; NA, not available; NR, patients did not reach the 10-year and 20-year follow-ups; NOS, not otherwise specified.

Data are % unless otherwise specified.

Cox proportional hazard regression models for multivariable analysis adjusted for collected covariates. All patient factors, tumor characteristics, and treatment patterns were entered in the final model.

Bold indicates a significant P value.